What is the recommended approach to combining medications from different classes in glaucoma management?

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What is the recommended approach to combining medications from different classes in glaucoma management?

Explanation:
In POAG management, the goal is to lower intraocular pressure effectively with the simplest, safest regimen. Prostaglandin analogs are a powerful first-line option and are usually given once daily. However, adding a second prostaglandin yields only a small extra drop in pressure because both drugs act through the same mechanism, and it increases the chance of local side effects (like conjunctival redness and irritation) and cost without much additional benefit. Therefore, when more IOP lowering is needed, the better approach is to add a medication from a different class—such as a beta-blocker, a carbonic anhydrase inhibitor, or an alpha-2 agonist—or switch to a fixed-dose combination that pairs a different mechanism with the prostaglandin, rather than mixing two prostaglandin analogs with other classes all at once. This helps maximize efficacy while limiting side effects and treatment burden.

In POAG management, the goal is to lower intraocular pressure effectively with the simplest, safest regimen. Prostaglandin analogs are a powerful first-line option and are usually given once daily. However, adding a second prostaglandin yields only a small extra drop in pressure because both drugs act through the same mechanism, and it increases the chance of local side effects (like conjunctival redness and irritation) and cost without much additional benefit. Therefore, when more IOP lowering is needed, the better approach is to add a medication from a different class—such as a beta-blocker, a carbonic anhydrase inhibitor, or an alpha-2 agonist—or switch to a fixed-dose combination that pairs a different mechanism with the prostaglandin, rather than mixing two prostaglandin analogs with other classes all at once. This helps maximize efficacy while limiting side effects and treatment burden.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy